Prezentacja kosztów B+R w raportach rocznych europejskich spółek biotechnologicznych
Presentation of R&D costs in annual reports of biotechnological companies

Summary/Abstract: The paper refers to diverse approaches of disclosure and presentation ofinformation concerning R&D costs in the narrative parts of annual reports. Selectedbiotechnological companies which were ranked by EU R&D Scoreboard 2014 became thereasearch objects in this study. The study focused on R&D cost classification, disclosure offactors which influenced the level of R&D cost, presence of R&D cost in a profit and lossaccount. The paper is composed of three sections. The first part delineates Europeanbiotechnological sector in terms of R&D cost level and R&D intensity. The second sectionpresents regulatory issues associated with the recognition of R&D costs in the annual reportsin compliance with IFRS or US GAAP. The last part of the paper, which is based on casestudies’ analysis, shows how European biotechnological companies presented and disclosedtheir financial and non-financial information on R&D costs in reporting practice.

• Details
• Contents